1. P10 Weight loss is a feature of progressive disease in idiopathic pulmonary fibrosis. (12th November 2019) Authors: Barth, S; Hogben, C; King, M; Vitri, B; Mann, J; George, P; Kokosi, M; Kouranos, V; Renzoni, E; Wells, AU; Chua, F; Maher, TM; Molyneaux, PL Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P157 Hiatus hernia is highly prevalent in idiopathic pulmonary fibrosis and impacts disease progression. (December 2018) Authors: Desai, SR; Mackintosh, JA; Chua, F; Renzoni, E; Kouranos, V; Margaritopoulos, G; Kokosi, M; Maher, TM; Wells, AU; Molyneaux, PL; Kumar, S; George, PM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P160 Bone protection in oral corticosteroid dependant asthmatics. (12th November 2015) Authors: Hashim, HH; Molyneaux, PL; Regan, S; Hull, JH; Menzies-Gow, A Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P164 Cyclophosphamide for the treatment of refractory chronic hypersensitivity pneumonitis. (December 2018) Authors: Hastings, RA; Saunders, P; Hogben, C; Mackintosh, JA; Patel, S; Chua, F; Renzoni, EA; Kokosi, M; Kouranos, V; Wells, AU; George, PM; Maher, TM; Molyneaux, PL Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P26 Impact of hiatus hernia in hypersensitivity pneumonitis – experience at a tertiary centre. (11th November 2022) Authors: Heriot, DA; Stock, CJW; Mumtaz, Z; Jenkins, RG; Chua, F; Molyneaux, PL; Devaraj, A; Kouranos, V; Wells, AU; Renzoni, EA; Padley, SPG; Desai, SR; George, PM Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P28 Prognostic value of routine peripheral blood markers in fibrotic hypersensitivity pneumonitis. (11th November 2022) Authors: Stock, CJW; Bray, W; Kokosi, M; Kouranos, V; George, PM; Molyneaux, PL; Chua, F; Jenkins, GR; Wells, AU; Renzoni, EA Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P56 Use of the Tuberculin Skin Test and Tspot For Screening Prior to TNF Antagonist Therapy Identifies Additional Patients Eligible For Chemoprophylaxis Compared to Use of Risk Assessment Strategies Alone. (19th November 2012) Authors: Manalan, K; Singanayagam, A; Molyneaux, PL; George, PM; Connell, DW; Lalvani, A; Wickremasinghe, M; Kon, OM Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P7 The safety of bronchoalveolar lavage in patients with idiopathic pulmonary fibrosis. (12th November 2019) Authors: Smith, J; Chua, FJ; Wells, AU; Renzoni, E; Nicholson, AG; Jenkins, RG; Marshall, RP; Fahy, WA; Maher, TM; Molyneaux, PL Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S109 Genome-wide analysis of longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis. (11th November 2022) Authors: Allen, RJ; Oldham, JM; Jenkins, DA; Leavy, OC; Guillen-Guio, B; Melbourne, CA; Ma, SF; Jou, J; Kim, JS; Fahy, WA; Oballa, E; Hubbard, RB; Navaratnam, V; Braybrooke, R; Saini, G; Roach, KM; Tobin, MD; Hirani, N; Whyte, MKB; Kaminski, N Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S143 Serum CYFRA 21–1 as a prognostic marker in scleroderma-associated interstitial lung disease. (December 2018) Authors: Stock, CJW; Hoyles, R; D'accord, C; Kokosi, M; Alfieri, V; Campochiaro, C; Donovan, J; Mori, L; Maher, TM; Kouranos, V; Margaritopoulos, G; George, PM; Molyneaux, PL; Chua, F; Abraham, DJ; Ong, V; Denton, CP; Wells, AU; Renzoni, EA Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗